Diagnosis of bladder tumors during pregnancy is quite unusual considering the low frequency of neoplasias in the period (1/1000 pregnancies), as well as the low incidence of bladder cancer in patients younger than age 30. 1 Primary transitional cell carcinoma of the bladder occurring during pregnancy is extremely rare, and only 16 patients have been reported in the literature as of November 1994. 2 Most tumors are discovered by ultrasound when hematuria is mistaken for vaginal bleeding or during routine obstetrical scans, as was the scenario in this case.
Case Presentation
A patient in her early 20s, gravida 2 para 1, presented to our office for routine obstetrical care. On initial visit, the patient was estimated to be 7 weeks gestational age by last monthly period. The patient expressed no complaints, and lab findings were normal. At 14 weeks gestational age, the patient was brought into the office due to bleeding. A urinalysis was done that showed a result of 4+ blood. Otherwise the examination was normal. The patient was given urinary tract infection medications and routine precautions with regard to continued bleeding or problems. The patient returned at 16 weeks gestational age for a routine visit and ultrasound. A transabdominal ultrasound using a 5.0 MHz curvilinear probe (RT 3200, General Electric) identified an irregular echogenic mass in maternal bladder at the inferior aspect of the bladder. The mass measured 2.1 × 1.5 × 1.7 cm (Figs. 1, 2). At the time this case presented, color Doppler technology was not available to the sonographer.
Fetal survey was unremarkable for anomalies, and fetal size was consistent with dates. No placenta previa or abruption was identified. The patient was referred to a urologist for evaluation of maternal bladder mass. The mass was evaluated by cystoscope, with subsequent removal. Pathology of the bladder mass indicated a papillary transitional cell carcinoma, grade II of IV grades, moderately differentiate. The patient was noted to be a tobacco user but had reduced her use of tobacco during the pregnancy. The pregnancy continued uneventful, with spontaneous vaginal delivery of a healthy male infant. Follow-up cystoscope studies showed no evidence of recurrent disease. Postremoval images of maternal bladder were not available due to the referral of the patient to a urologist for evaluation and treatment during pregnancy and postpregnancy follow-up. 
Discussion
Transitional cell carcinoma of the bladder occurring during pregnancy is rare. During pregnancy, the immunological mechanisms undergo marked changes. There appears to be a generalized depression of the pregnant patient's immune system. The exact mechanism for the depression of the immune system is not known. 3 Certain neoplasms (ie, carcinoma of the cervix and melanoma) grow more rapidly in the environment of a concomitant pregnancy, 3 and the patient is adversely affected. The effects of pregnancy on transitional cell carcinoma of the bladder have not been clearly defined. 3 Researchers have found that Caucasians have twice the incidence of bladder cancer as African Americans and that the male:female ratio is approximately 3:1. Patients with transitional cell carcinoma of the bladder are usually older than 40 years of age. Risk factors include family history of bladder cancer, smoking, and occupational risks. Workers in some occupations are at higher risk due to exposure to carcinogens in the workplace. Continuous exposure to carcinogens/irritants may lead to accumulation of genetic mutations that are oncogenic. Renal tract neoplasms account for only 15% of all cases of hematuria. 4 Most bladder cancers (about 98%) occur within the transitional epithelium, or surface layer of tissue that lines the bladder. Approximately 90% of bladder cancers are transitional cell carcinomas. All epithelial tumors are thought to begin in transitional epithelium. Transitional cell carcinoma is the most common form of bladder cancer. Transitional cell carcinoma usually occurs as a superficial papillary exophytic (outward-growing) mass upon a stalk-like base protruding into the bladder lumen. In some cases, transitional cell carcinoma may be attached on a broad base or it may appear ulcerated (within an indented lesion). Both types can invade the muscular wall of the bladder. Papillary transitional cell carcinomas (as was the lesion in this case) make up 70% of all transitional cell carcinomas. They usually are low grade and noninvasive at the time of appearance and are characterized by multiple recurrences. Papillary transitional cell carcinomas often start out as areas of hyperplasia that later lose individual cell characteristics. Only about 10% to 30% of papillary transitional cell carcinomas develop into invasive cancers. Grading of tumors is primarily based on the cytologic features of the epithelium, and subsequent treatment will be determined by the grade and, in pregnancy, the trimester.
In years past, we have required a maximum-filled bladder, which enabled the sonographer to image the uterine-bladder interface. Now with the scanning criterion of a partially filled bladder, the sonographer may image thickened areas along the bladder wall or even nodular irregularities. The thickened areas or nodular irregularities could be caused by the lack of maximum bladder filling, and these areas are bladder folds rather than true areas of thickening or masses projecting into bladder lumen. If the sonographer is suspicious of an area, the bladder should be filled to maximum and rescanned. I have seen these areas become normal in appearance with the bladder full. A number of factors can affect detection of bladder tumors by ultrasound. These include not only bladder distention but also obesity, blood clots, cystitis, and bladder trabeculation. 5 Hematuria during pregnancy is usually associated with infection; however, neoplasms must be included in the differential diagnosis. 4 Cystoscopy should be considered in all pregnant women with documented gross hematuria or persistent microscopic hematuria, especially in the absence of infection, since cystoscopy can be easily and safely performed during pregnancy. 5 Small transitional cell carcinomas of the bladder during pregnancy can be treated safely by transurethral resection of the tumors. 2 Transurethral resection appears to be the procedure of choice in the management of this condition and carries minimal morbidity even when performed during pregnancy. 6 Superficial bladder tumors should be treated promptly by conventional means (cystoscopy with transurethral resection). Only late in pregnancy is a delay in treatment or early delivery justified. 5 Invasive tumors present a much greater challenge, and treatment would have to be individualized based on stage, type, and trimester of pregnancy. 5 This case emphasizes the importance of hematuria when dealing with a patient with antepartum hemorrhage. 7 It is the duty of the sonographer to be diligent in scanning maternal pelvic structures at routine scans regardless of whether antepartum bleeding is present. The sonographer should evaluate not only placenta situations when bleeding is present but also fetal and maternal anatomy for abnormal findings. In this case, the antepartum bleeding was presumed to be a urinary tract infection and the bladder tumor an incidental finding on a routine obstetrical ultrasound. There have been cases in which a bladder mass was discovered during a screening obstetrical ultrasound with no complaint of antepartum bleeding or urological problems. Urological tumors may be mistaken for other more common diagnoses such as urinary tract infection, pyelitis, threatened abortion, and abnormal placenta conditions. 8, 9 
